terconazole 80 MG Vaginal Insert

What the CMS Formulary Data Shows for terconazole 80 MG Vaginal Insert

Per the CMS 2026 Part D formulary file, terconazole 80 MG Vaginal Insert (RxNorm concept RXCUI 198245, generic name terconazole) appears on 303 distinct formulary files spanning 4,910 Medicare Part D plan offerings - 96.9% of enrollable Part D products, near-universal placement. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 2.6.

Real-world access to terconazole 80 MG Vaginal Insert depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.

Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 84,152 Part D beneficiaries filled terconazole 80 MG Vaginal Insert in 2023, with total plan-and-beneficiary spending of $4,059,954 and an average per-beneficiary annual cost of $48.25. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry terconazole 80 MG Vaginal Insert today.